Latest Breaking News On - Hans lindner - Page 1 : comparemela.com
Germany: Schoolgirls Warned to Walk to School in Groups After Tunisian Migrant Rapes Woman Near School Grounds
amren.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from amren.com Daily Mail and Mail on Sunday newspapers.
Dank an Mann der ersten Stunde
pnp.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pnp.de Daily Mail and Mail on Sunday newspapers.
Posted on 388
ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, and NUVISAN Innovation Campus Berlin (ICB) GmbH, a fully integrated contract research service provider for drug discovery and early development programs, today announced a non-exclusive license agreement granting NUVISAN ICB access to ERS Genomics’ CRISPR/Cas9 patent portfolio.
NUVISAN ICB originated from a spin-out of the major pharma R&D functions of BAYER, which were acquired by NUVISAN in 2020. With its fully functional capabilities and capacities to support the entire drug discovery value chain, NUVISAN ICB offers integrated programs from target discovery to the clinic, including lead discovery, medicinal chemistry, pharmacology, drug metabolism and investigational toxicology. NUVISAN ICB’s growing list of new clients comprises top pharmaceuti